Global COVID-19 Diagnostic Testing Market

Focus on Product Type, Sample Type, Technology, End User, Country Data (30 Countries), and Competitive Landscape - Analysis and Forecast, 3Q-2020-4Q-2021

Published Year: 2020
SKU: BHP0959SA

5000

Online Access for One Person. Permission to Print

A quick peek into the report

Table of Contents

Download this TOC  

Request a Sample

1 Product Definition

1.1    Inclusion and Exclusion

2 Research Scope

2.1    Scope of the Study
2.2    Key Questions Answered in the Report

3 Research Methodology

3.1    COVID-19 Diagnostic Testing: Research Methodology
3.2    Data Sources
         3.2.1    Primary Data Sources
         3.2.2    Secondary Data Sources
3.3    Market Estimation Model

4 Market Overview

4.1    Market Definition
4.2    Impact of COVID-19 on Human Health
4.3    Implications of COVID-19 on the Healthcare Sector
4.4    Market Footprint and Growth Potential, Value ($Million), 2020-2021

5 Industry Insights

5.1    Overview
5.2    Legal Requirements and Framework in the U.S.
         5.2.1    Emergency Use Authorization (EUA)
5.3    Legal Requirements and Framework in Europe
5.4    Legal Requirement and Framework in the Asia-Pacific Region
         5.4.1    China
         5.4.2    Japan

6 Market Dynamics

6.1    Overview
6.2    Impact Analysis
6.3    Drivers
         6.3.1    Rising Cases of COVID-19 Globally, Inciting the Development of Diagnostic Tests
         6.3.2    Technological Innovation Resulting in Market Pull
         6.3.3    Significant External Funding Supporting Market Growth
         6.3.4    Favorable Regulatory Scenario Aiding Companies to Launch COVID-19 Diagnostic Testing Products
6.4    Restraints
         6.4.1    Less Efficient Rapid COVID-19 Diagnostic Testing as Compared to Laboratory Testing
         6.4.2    Shortage of Skilled Professionals and Trained Lab-Technicians
         6.4.3    Shortage of COVID-19 Diagnostic Test Reagents
         6.4.4    Significant Dampening of the Market Due to the Expected Launch of COVID-19 Vaccine
         6.4.5    Massive Scope for Adoption of COVID-19 Point-of-Care (POC) Testing Products in Emerging Nations

7 Competitive Landscape

7.1    Key Strategies and Developments
         7.1.1    Product Approvals
         7.1.2    Synergistic Activities
         7.1.3    Product Launch and Upgradations
         7.1.4    Business Expansion and Funding
7.2    Market Share Analysis

8 Global COVID-19 Diagnostic Testing Market (by Product)

8.1    Overview
8.2    Kits and Assays
8.3    Instruments

9 Global COVID-19 Diagnostic Testing Market (by Sample Type)

9.1    Overview
9.2    Swabs
         9.2.1    Nasopharyngeal Swabs
         9.2.2    Oropharyngeal Swabs
9.3    Blood Samples
9.4    Urine Samples
9.5    Other Samples

10 Global COVID-19 Diagnostic Testing Market (by Technology)

10.1    Overview
10.2    Molecular Assays
           10.2.1    Polymerase Chain Reaction (PCR)
                         10.2.1.1    Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR)
                         10.2.1.2    Droplet Digital Polymerase Chain Reaction (ddPCR)
           10.2.2    Isothermal Amplification
           10.2.3    Others
10.3    Immunoassays
           10.3.1    Lateral Flow Immunoassay (LFIA)
           10.3.2    Enzyme Immunoassay (EIA)

11 Global COVID-19 Diagnostic Testing Market (by End User)

11.1    Overview
11.2    Hospitals and Healthcare Centers
11.3    Diagnostic Centers and Clinics
11.4    Research Institutions
11.5    Other End Users

12 Global COVID-19 Diagnostic Testing Market (by Region)

12.1    Overview
12.2    North America
           12.2.1    U.S.
                         12.2.1.1    Strategies Adopted by the U.S. for COVID-19 Diagnostic Testing
                         12.2.1.2    U.S. COVID-19 Diagnostic Testing Market (by Technology)
                                          12.2.1.2.1    Molecular Assays
                                          12.2.1.2.2    Immunoassay
           12.2.2    Canada
                         12.2.2.1    Strategies Adopted by Canada for COVID-19 Diagnostic Testing
                         12.2.2.2    Canada COVID-19 Diagnostic Testing Market (by Technology)
                                          12.2.2.2.1    Molecular Assays
                                          12.2.2.2.2    Immunoassays
           12.2.3    Rest-of-North America
                         12.2.3.1    Rest-of-North America COVID-19 Diagnostic Testing Market (by Technology)
                                          12.2.3.1.1    Molecular Assays
                                          12.2.3.1.2    Immunoassays
12.3    Europe
           12.3.1    Germany
                         12.3.1.1    Strategies Adopted by Germany for COVID-19 Diagnostic Testing
                         12.3.1.2    Germany COVID-19 Diagnostic Testing Market (by Technology)
                                          12.3.1.2.1    Molecular Assays
                                          12.3.1.2.2    Immunoassays
           12.3.2    U.K.
                         12.3.2.1    Strategies Adopted by the U.K. for COVID-19 Diagnostic Testing
                         12.3.2.2    U.K. COVID-19 Diagnostic Testing Market (by Technology)
                                          12.3.2.2.1    Molecular Assays
                                          12.3.2.2.2    Immunoassays
           12.3.3    France
                         12.3.3.1    Strategies Adopted by France for COVID-19 Diagnostic Testing
                         12.3.3.2    France COVID-19 Diagnostic Testing Market (by Technology)
                                          12.3.3.2.1    Molecular Assays
                                          12.3.3.2.2    Immunoassays
           12.3.4    Italy
                         12.3.4.1    Strategies Adopted by Italy for COVID-19 Diagnostic Testing
                         12.3.4.2    Italy COVID-19 Diagnostic Testing Market (by Technology)
                                          12.3.4.2.1    Molecular Assays
                                          12.3.4.2.2    Immunoassays
           12.3.5    Spain
                         12.3.5.1    Strategies Adopted by Spain for COVID-19 Diagnostic Testing
                         12.3.5.2    Spain COVID-19 Diagnostic Testing Market (by Technology)
                                          12.3.5.2.1    Molecular Assays
                                          12.3.5.2.2    Immunoassays
           12.3.6    Russia
                         12.3.6.1    Russia COVID-19 Diagnostic Testing Market (by Technology)
                                          12.3.6.1.1    Molecular Assays
                                          12.3.6.1.2    Immunoassays
           12.3.7    Netherlands
                         12.3.7.1    Strategies Adopted by Netherlands for COVID-19 Diagnostic Testing
                         12.3.7.2    Netherlands COVID-19 Diagnostic Testing Market (by Technology)
                                          12.3.7.2.1    Molecular Assays
                                          12.3.7.2.2    Immunoassays
           12.3.8    Rest-of-Europe
                         12.3.8.1    Rest-of-Europe COVID-19 Diagnostic Testing Market (by Technology)
                                          12.3.8.1.1    Molecular Assays
                                          12.3.8.1.2    Immunoassays
12.4    Asia-Pacific
           12.4.1    China
                         12.4.1.1    Strategies Adopted by China for COVID-19 Diagnostic Testing
                         12.4.1.2    China COVID-19 Diagnostic Testing Market (by Technology)
                                          12.4.1.2.1    Molecular Assays
                                          12.4.1.2.2    Immunoassays
           12.4.2    India
                         12.4.2.1    Strategies Adopted by India for COVID-19 Diagnostic Testing
                         12.4.2.2    India COVID-19 Diagnostic Testing Market (by Technology)
                                          12.4.2.2.1    Molecular Assays
                                          12.4.2.2.2    Immunoassays
           12.4.3    Japan
                         12.4.3.1    Strategies Adopted by Japan for COVID-19 Diagnostic Testing
                         12.4.3.2    Japan COVID-19 Diagnostic Testing Market (by Technology)
                                          12.4.3.2.1    Molecular Assays
                                          12.4.3.2.2    Immunoassays
           12.4.4    Taiwan
                         12.4.4.1    Strategies Adopted by Taiwan for COVID-19 Diagnostic Testing
                         12.4.4.2    Taiwan COVID-19 Diagnostic Testing Market (by Technology)
                                          12.4.4.2.1    Molecular Assays
                                          12.4.4.2.2    Immunoassays
           12.4.5    South Korea
                         12.4.5.1    Strategies Adopted by South Korea for COVID-19 Diagnostic Testing
                         12.4.5.2    South Korea COVID-19 Diagnostic Testing Market (by Technology)
                                          12.4.5.2.1    Molecular Assays
                                          12.4.5.2.2    Immunoassays
           12.4.6    Singapore
                         12.4.6.1    Strategies Adopted by Singapore for COVID-19 Diagnostic Testing
                         12.4.6.2    Singapore COVID-19 Diagnostic Testing Market (by Technology)
                                          12.4.6.2.1    Molecular Assays
                                          12.4.6.2.2    Immunoassays
           12.4.7    Australia
                         12.4.7.1    Strategies Adopted by Australia for COVID-19 Diagnostic Testing
                         12.4.7.2    Australia COVID-19 Diagnostic Testing Market (by Technology)
                                          12.4.7.2.1    Molecular Assays
                                          12.4.7.2.2    Immunoassays
           12.4.8    Bangladesh
                         12.4.8.1    Strategies Adopted by Bangladesh for COVID-19 Diagnostic Testing
                         12.4.8.2    Bangladesh COVID-19 Diagnostic Testing Market (by Technology)
                                          12.4.8.2.1    Molecular Assays
                                          12.4.8.2.2    Immunoassays
           12.4.9    Pakistan
                         12.4.9.1    Strategies Adopted by Pakistan for COVID-19 Diagnostic Testing
                         12.4.9.2    Pakistan COVID-19 Diagnostic Testing Market (by Technology)
                                          12.4.9.2.1    Molecular Assays
                                          12.4.9.2.2    Immunoassays
         12.4.10    Indonesia
                         12.4.10.1    Strategies Adopted by Indonesia for COVID-19 Diagnostic Testing
                         12.4.10.2    Indonesia COVID-19 Diagnostic Testing Market (by Technology)
                                            12.4.10.2.1    Molecular Assays
                                            12.4.10.2.2    Immunoassays
         12.4.11    Rest-of-APAC(RoAPAC)
                         12.4.11.1    Rest-of-APAC COVID-19 Diagnostic Testing Market (by Technology)
                                            12.4.11.1.1    Molecular Assays
                                            12.4.11.1.2    Immunoassays
12.5    Latin America
           12.5.1    Brazil
                         12.5.1.1    Strategies Adopted by Brazil for COVID-19 Diagnostic Testing
                         12.5.1.2    Brazil COVID-19 Diagnostic Testing Market (by Technology)
                                          12.5.1.2.1    Molecular Assays
                                          12.5.1.2.2    Immunoassays
           12.5.2    Mexico
                         12.5.2.1    Strategies Adopted by Mexico for COVID-19 Diagnostic Testing
                         12.5.2.2    Mexico COVID-19 Diagnostic Testing Market (by Technology)
                                          12.5.2.2.1    Molecular Assays
                                          12.5.2.2.2    Immunoassays
           12.5.3    Peru
                         12.5.3.1    Strategies Adopted by Peru for COVID-19 Diagnostic Testing
                         12.5.3.2    Peru COVID-19 Diagnostic Testing Market (by Technology)
                                          12.5.3.2.1    Molecular Assays
                                          12.5.3.2.2    Immunoassays
            12.5.4    Argentina
                         12.5.4.1    Strategies Adopted by Argentina for COVID-19 Diagnostic Testing
                         12.5.4.2    Argentina COVID-19 Diagnostic Testing Market (by Technology)
                                          12.5.4.2.1    Molecular Assays
                                          12.5.4.2.2    Immunoassays
           12.5.5    Chile
                         12.5.5.1    Strategies Adopted by Chile for COVID-19 Diagnostic Testing
                         12.5.5.2    Chile COVID-19 Diagnostic Testing Market (by Technology)
                                          12.5.5.2.1    Molecular Assays
                                          12.5.5.2.2    Immunoassays
           12.5.6    Rest-of-Latin America (RoLA)
                         12.5.6.1    Rest-of-Latin America COVID-19 Diagnostic Testing Market (by Technology)
                                          12.5.6.1.1    Molecular Assays
                                          12.5.6.1.2    Immunoassays
12.6    Middle East
           12.6.1    Kingdom of Saudi Arabia
                         12.6.1.1    Strategies Adopted by KSA for COVID-19 Diagnostic Testing
                         12.6.1.2    KSA COVID-19 Diagnostic Testing Market (by Technology)
                                          12.6.1.2.1    Molecular Assays
                                          12.6.1.2.2    Immunoassays
           12.6.2    Iran
                         12.6.2.1    Strategies Adopted by Iran for COVID-19 Diagnostic Testing
                         12.6.2.2    Iran COVID-19 Diagnostic Testing Market (by Technology)
                                          12.6.2.2.1    Molecular Assays
                                          12.6.2.2.2    Immunoassays
           12.6.3    United Arab Emirates (U.A.E.)
                         12.6.3.1    U.A.E. COVID-19 Diagnostic Testing Market (by Technology)
                                          12.6.3.1.1    Molecular Assays
                                          12.6.3.1.2    Immunoassays
           12.6.4    Rest-of-Middle East
                         12.6.4.1    Rest-of-Middle East COVID-19 Diagnostic Testing Market (by Technology)
                                          12.6.4.1.1    Molecular Assays
                                          12.6.4.1.2    Immunoassays
12.7    Africa
           12.7.1    South Africa
                         12.7.1.1    Strategies Adopted by South Africa for COVID-19 Diagnostic Testing
                         12.7.1.2    South Africa COVID-19 Diagnostic Testing Market (by Technology)
                                          12.7.1.2.1    Molecular Assays
                                          12.7.1.2.2    Immunoassays
           12.7.2    Zimbabwe
                         12.7.2.1    Zimbabwe COVID-19 Diagnostic Testing Market (by Technology)
                                          12.7.2.1.1    Molecular Assays
                                          12.7.2.1.2    Immunoassays
           12.7.3    Algeria
                         12.7.3.1    Algeria COVID-19 Diagnostic Testing Market (by Technology)
                                          12.7.3.1.1    Molecular Assays
                                           12.7.3.1.2    Immunoassays
           12.7.4    Rest-of-Africa
                         12.7.4.1    Rest-of-Africa COVID-19 Diagnostic Testing Market (by Technology)
                                          12.7.4.1.1    Molecular Assays
                                          12.7.4.1.2    Immunoassays
12.8    Oceania/Rest-of-the-World
           12.8.1    Oceania/RoW COVID-19 Diagnostic Testing Market (by Technology)
           12.8.2    Molecular Assays
           12.8.3    Immunoassays

13 Company Profiles

13.1    Overview
13.2    Abbott Laboratories
           13.2.1    Company Overview
           13.2.2    BIS Insights
13.3    BGI Group
           13.3.1    Company Overview
           13.3.2    BIS Insights
13.4    Becton, Dickinson and Company
           13.4.1    Company Overview
           13.4.2    BIS Insights
13.5    BioMerieux SA
           13.5.1    Company Overview
           13.5.2    BIS Insights
13.6    Bio-Rad Laboratories, Inc.
           13.6.1    Company Overview
           13.6.2    BIS Insights
13.7    CENTOGENE Holding AG
           13.7.1    Company Overview
           13.7.2    BIS Insights
13.8    Cellex Inc.
           13.8.1    Company Overview
           13.8.2    BIS Insights
13.9    CTK Biotech
           13.9.1    Company Overview
           13.9.2    BIS Insights
13.10    Danaher Corporation
             13.10.1    Company Overview
             13.10.2    BIS Insights
13.11    DiaSorin S.p.A
             13.11.1    Company Overview
             13.11.2    BIS Insights
13.12    F. Hoffmann-La Roche Ltd
             13.12.1    Company Overview
             13.12.2    BIS Insights
13.13    Hologic, Inc.
             13.13.1    Company Overview
             13.13.2    BIS Insights
13.14    GenMark Diagnostics
             13.14.1    Company Overview
             13.14.2    BIS Insights
13.15    PerkinElmer Inc.
             13.15.1    Company Overview
             13.15.2    BIS Insights
13.16    QIAGEN N.V.
             13.16.1    Company Overview
             13.16.2    BIS Insights
13.17    Quidel Corporation
             13.17.1    Company Overview
             13.17.2    BIS Insights
13.18    Luminex Corporation
             13.18.1    Company Overview
             13.18.2    BIS Insights
13.19    Siemens Healthineers AG
             13.19.1    Company Overview
             13.19.2    BIS Insights
13.20    Thermo Fisher Scientific Inc.
             13.20.1    Company Overview
             13.20.2    BIS Insights

List of Tables

Table 5.1:    Registration Criteria for IVD Medical Devices as per the NMPA
Table 6.1:    Impact Analysis of Market Drivers
Table 6.2:    Impact Analysis of Market Restraints
Table 12.1:    Key Players Offering Molecular Assays in the U.S.
Table 12.2:    Key Players Offering Immunoassays in the U.S.
Table 12.3:    Key Players Offering Molecular Assays in Canada
Table 12.4:    Key Players Offering Immunoassays in Canada
Table 12.5:    Key Players Offering Molecular Assays in Germany
Table 12.6:    Key Players Offering Immunoassays in Germany
Table 12.7:    Key Players Offering Molecular Assays in the U.K.
Table 12.8:    Key Players Offering Immunoassays in the U.K.
Table 12.9:    Key Players Offering Molecular Assays in France
Table 12.10:    Key Players Offering Molecular Assays in France
Table 12.11:    Key Players Offering Molecular Assays in Italy
Table 12.12:    Key Players Offering Immunoassays in Italy
Table 12.13:    Key Players Offering Molecular Assays in Spain
Table 12.14:    Key Players Offering Immunoassays in Spain
Table 12.15:    Key Players Offering Molecular Assays in Netherlands
Table 12.17:    Key Players Offering Molecular Assays in China
Table 12.18:    Key Players Offering Immunoassays in China
Table 12.19:    Key Players Offering Molecular Assays in India
Table 12.20:    Key Players Offering Immunoassays in India
Table 12.21:    Key Players Offering Molecular Assays in Japan
Table 12.22:    Key Players Offering Immunoassays in Japan
Table 12.23:    Key Players Offering Molecular Assays in Taiwan
Table 12.24:    Key Players Offering Molecular Assays in South Korea
Table 12.25:    Key Players Offering Immunoassays in South Korea
Table 12.26:    Key Players Offering Molecular Assays in Singapore
Table 12.27:    Key Players Offering Immunoassays in Singapore
Table 12.28:    Key Players Offering Molecular Assays in Australia
Table 12.29:    Key Players Offering Immunoassays in Australia

List of Figures

Figure 1:    Global COVID-19 Cumulative Cases
Figure 2:    Impact Analysis of Market Drivers and Market Challenges on the Global COVID-19 Diagnostic Testing Market
Figure 3:    Global COVID-19 Diagnostic Testing Market (by Product), Value ($Million), 2Q2020-4Q2021
Figure 4:    Global COVID-19 Diagnostic Testing Market (by Sample Type), Value ($Million), 2Q2020-4Q2021
Figure 5:    Global COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 2Q2020-4Q2021
Figure 6:    Global COVID-19 Diagnostic Testing Market (by End User), Value ($Million), 2Q2020-4Q2021
Figure 7:    Global COVID-19 Diagnostic Testing Market (by Region), Value ($Million),  2Q2020-4Q2021
Figure 2.1:    Global COVID-19 Diagnostic Testing Market Segmentation
Figure 3.1:    Global COVID-19 Diagnostic Testing Market: Research Methodology
Figure 3.2:    Primary Research Methodology
Figure 3.3:    Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4:    Top-Down Approach (Segment-Wise Analysis)
Figure 4.1:    Implications of COVID-19 on the Healthcare Sector: Short- and Long-Term Analysis
Figure 4.2:    Global COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020 and 4Q2021
Figure 5.1:    Procedure for Obtaining Emergency Use Authorization (EUA)
Figure 5.2:    Components Considered for Clinical Evidence as per the IVDR
Figure 5.3:    Procedure for IVD Medical Device Registration in China
Figure 6.1:    Number of COVID-19 Confirmed Cases, Globally
Figure 7.1:    Share of Key Developments and Strategies, January 2020 - July 2020
Figure 7.2:    Product Approval Share (by Company), January 2020 – July 2020
Figure 7.3:    Synergistic Activities Share (by Company), January 2020 – July 2020
Figure 7.4:    Product Launch and Upgradations Share (by Company), January 2020 – July 2020
Figure 7.6:    Market Share Analysis for Global COVID-19 Diagnostic Testing Market, 2Q2020
Figure 8.1:    Global COVID-19 Diagnostic Testing Market (by Product Type)
Figure 8.2:    Global COVID-19 Diagnostic Testing Market (by Product Type), 2Q2020 and 4Q2021
Figure 8.3:    Global COVID-19 Diagnostic Testing Market (for Kits and Assays), Value ($Million), 1Q2020-4Q2021
Figure 8.4:    Global COVID-19 Diagnostic Testing Market (for Instruments), Value ($Million), 1Q2020-4Q2021
Figure 9.1:    Global COVID-19 Diagnostic Testing Market (by Sample Type)
Figure 9.2:    Global COVID-19 Diagnostic Testing Market (by Sample Type), 2Q2020-4Q2021
Figure 9.3:    Global COVID-19 Diagnostic Testing Market (by Swab), 2Q2020 and 4Q2021
Figure 9.4:    Global COVID-19 Diagnostic Testing Market (for Nasopharyngeal Swabs), Volume (Thousand Units), 1Q2020-4Q2021
Figure 9.5:    Global COVID-19 Diagnostic Testing Market (for Nasopharyngeal Swabs), Value ($Million), 1Q2020-4Q2021
Figure 9.6:    Global COVID-19 Diagnostic Testing Market (for Oropharyngeal Swabs), Volume (Thousand Units), 1Q2020-4Q2021
Figure 9.7:    Global COVID-19 Diagnostic Testing Market (for Oropharyngeal Swabs), Value ($Million), 1Q2020-4Q2021
Figure 9.8:    Global COVID-19 Diagnostic Testing Market (for Blood Samples), Volume (Thousand Units), 1Q2020-4Q2021
Figure 9.9:    Global COVID-19 Diagnostic Testing Market (for Blood Samples), Value ($Million), 1Q2020-4Q2021
Figure 9.10:    Global COVID-19 Diagnostic Testing Market (for Urine Samples), Volume (Thousand Units), 1Q2020-4Q2021
Figure 9.11:    Global COVID-19 Diagnostic Testing Market (for Urine Samples), Value ($Million), 1Q2020-4Q2021
Figure 9.12:    Global COVID-19 Diagnostic Testing Market (for Other Samples), Volume (Thousand Units), 1Q2020-4Q2021
Figure 9.13:    Global COVID-19 Diagnostic Testing Market (for Other Samples), Value ($Million), 1Q2020-4Q2021
Figure 10.1:    Global COVID-19 Diagnostic Testing Market (by Technology)
Figure 10.2:    Global COVID-19 Diagnostic Testing Market (by Technology), 2Q2020-4Q2021
Figure 10.3:    Global COVID-19 Diagnostic Testing Market (by Molecular Assays), 2Q2020 and 4Q2021
Figure 10.4:    Global COVID-19 Diagnostic Testing Market (for PCR), Value ($Million), 1Q2020-4Q2021
Figure 10.5:    Global COVID-19 Diagnostic Testing Market (for RT-PCR), Volume (Thousand Units), 1Q2020-4Q2021
Figure 10.6:    Global COVID-19 Diagnostic Testing Market (for RT-PCR), Value ($Million), 1Q2020-4Q2021
Figure 10.7:    Global COVID-19 Diagnostic Testing Market (for ddPCR), Volume (Thousand Units), 1Q2020-4Q2021
Figure 10.8:    Global COVID-19 Diagnostic Testing Market (for ddPCR), Value ($Million), 1Q2020-4Q2021
Figure 10.9:    Global COVID-19 Diagnostic Testing Market (for Isothermal Amplification), Volume (Thousand Units), 1Q2020-4Q2021
Figure 10.10:    Global COVID-19 Diagnostic Testing Market (for Isothermal Amplification), Value ($Million), 1Q2020-4Q2021
Figure 10.11:    Global COVID-19 Diagnostic Testing Market (for Others), Volume (Thousand Units), 1Q2020-4Q2021
Figure 10.12:    Global COVID-19 Diagnostic Testing Market (for Others), Value ($Million), 1Q2020-4Q2021
Figure 10.13:    Global COVID-19 Diagnostic Testing Market (by Immunoassays), 2Q2020 and 4Q2021
Figure 10.14:    Global COVID-19 Diagnostic Testing Market (for Later Flow Immunoassay), Volume (Thousand Units), 1Q2020-4Q2021
Figure 10.15:    Global COVID-19 Diagnostic Testing Market (for Later Flow Immunoassay), Value ($Million), 1Q2020-4Q2021
Figure 10.16:    Global COVID-19 Diagnostic Testing Market (for Enzyme Immunoassay), Volume (Thousand Units), 1Q2020-4Q2021
Figure 10.17:    Global COVID-19 Diagnostic Testing Market (for Enzyme Immunoassay), Value ($Million), 1Q2020-4Q2021
Figure 11.1:    Global COVID-19 Diagnostic Testing Market (by End User)
Figure 11.2:    Global COVID-19 Diagnostic Testing Market (by End User), 2Q2020-4Q2021
Figure 11.3:    Global COVID-19 Diagnostic Testing Market (for Hospitals and Healthcare Centers), Volume (Thousand Units), 1Q2020-4Q2021
Figure 11.4:    Global COVID-19 Diagnostic Testing Market (for Hospitals and Healthcare Centers), Value ($Million), 1Q2020-4Q2021
Figure 11.5:    Global COVID-19 Diagnostic Testing Market (for Diagnostic Centers and Clinics), Volume (Thousand Units), 1Q2020-4Q2021
Figure 11.6:    Global COVID-19 Diagnostic Testing Market (for Diagnostic Centers and Clinics), Value ($Million), 1Q 2020-4Q2021
Figure 11.7:    Global COVID-19 Diagnostic Testing Market (for Research Institutions), Volume (Thousand Units), 1Q2020-4Q2021
Figure 11.8:    Global COVID-19 Diagnostic Testing Market (for Research Institutions), Value ($Million), 1Q2020-4Q2021
Figure 11.9:    Global COVID-19 Diagnostic Testing Market (for Other End Users), Volume (Thousand Units), 1Q2020-4Q2021
Figure 11.10:    Global COVID-19 Diagnostic Testing Market (for Other End Users), Value ($Million), 1Q2020-4Q2021
Figure 12.1:    Global COVID-19 Diagnostic Testing Market (by Region)
Figure 12.2:    Global COVID-19 Diagnostic Testing Market (by Region), Value ($Million), 1Q2020-4Q2021
Figure 12.3:    Global COVID-19 Diagnostic Testing Market (by Region), 1Q2020 and 4Q2021
Figure 12.4:    North America COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.5:    North America COVID-19 Diagnostic Testing Market (by Country), Value ($Million), 1Q2020-4Q2021
Figure 12.6:    North America: Market Dynamics
Figure 12.7:    U.S. COVID-19 Diagnostic Testing Market, Value (Million), 1Q2020-4Q2021
Figure 12.8:    U.S. Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.9:    U.S. COVID-19 Diagnostic Testing Market (by Technology), 1Q2020-4Q2021
Figure 12.10:    U.S. COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.11:    U.S. COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), Q12020-4Q2021
Figure 12.12:    U.S. COVID-19 Diagnostic Testing Market (for Immunoassay), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.13:    U.S. COVID-19 Diagnostic Testing Market (for Immunoassay), Value ($Million), 2020-2021
Figure 12.14:    Canada COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.15:    Canada Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.16:    Canada COVID-19 Diagnostic Testing Market (by Technology), 1Q2020-4Q2021
Figure 12.17:    Canada COVID-19 Diagnostic Testing Market (for Molecular Assays, Volume (Thousand Units), Q12020-4Q2021
Figure 12.18:    Canada COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.19:    Canada COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), Q12020-Q42021
Figure 12.20:    Canada COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.21:    Rest-of-North America COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.22:    Rest-of-North America COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.23:    Rest-of-North America COVID-19 Diagnostic Testing Market (for Molecular Assays, Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.24:    Rest-of-North America COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), Q12020-4Q2021
Figure 12.25:    Rest-of-North America COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.26:    Rest-of-North America COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.27:    Europe COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.28:    Europe: Market Dynamics
Figure 12.29:    Europe COVID-19 Diagnostic Testing Market (by Country), Value ($Million), 1Q2020-4Q2021
Figure 12.30:    Germany COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.31:    Germany Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.32:    Germany COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.33:    Germany COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.34:    Germany COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.35:    Germany COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.36:    Germany COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.37:    U.K. COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.38:    U.K. Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.39:    U.K. COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.40:    U.K. COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.41:    U.K. COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.42:    U.K. COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.43:    U.K. COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.44:    France COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.45:    France Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.46:    France COVID-19 Diagnostic Testing Market (by Technology), Value ($Million) 1Q2020-4Q2021
Figure 12.47:    France COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.48:    France COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.49:    France COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.50:    France COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.51:    Italy COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.52:    Italy Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.53:    Italy COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.54:    Italy COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.55:    Italy COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.56:    Italy COVID-19 Diagnostic Testing Market (for Immunoassay), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.57:    Italy COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.58:    Spain COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.59:    Spain Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.60:    Spain COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.61:    Spain COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.62:    Spain COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.63:    Spain COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.64:    Spain COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.65:    Russia COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.66:    Russia Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.67:    Russia COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.68:    Russia COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.69:    Russia COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.70:    Russia COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.71:    Russia COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.72:    Netherlands COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.73:    Netherlands Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.74:    Netherlands COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.75:    Netherlands COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.76:    Netherlands COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.77:    Netherlands COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.78:    Netherlands COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.79:    Rest-of-Europe COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.80:    Rest-of-Europe COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.81:    Rest-of-Europe COVID-19 Diagnostic Testing Market (for Molecular Assays, Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.82:    Rest-of-Europe COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), Q12020-4Q2021
Figure 12.83:    Rest-of-Europe COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.84:    Rest-of-Europe COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.85:    Asia-Pacific COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.86:    APAC: Market Dynamics
Figure 12.87:    APAC COVID-19 Diagnostic Testing Market (by Country), Value ($Million), 1Q2020-4Q2021
Figure 12.88:    China COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.89:    China Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.90:    China COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.91:    The China COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.92:    The China COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.93:    China COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.94:    China COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.95:    India COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.96:    India Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.97:    India COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.98:    India COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.99:    India COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.100:    India COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.101:    India COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.102:    Japan COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.103:    Japan Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.104:    Japan COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.105:    Japan COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.106:    Japan COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.107:    Japan COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.108:    Japan COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.109:    Taiwan COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.110:    Taiwan Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.111:    Taiwan COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.112:    Taiwan COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.113:    Taiwan COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.114:    Taiwan COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.115:    Taiwan COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.116:    South Korea COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.117:    South Korea Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.118:    South Korea COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.119:    South Korea COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.120:    South Korea COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.121:    South Korea COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.122:    South Korea COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.123:    Singapore COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.124:    Singapore Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.125:    Singapore COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.126:    Singapore COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.127:    Singapore COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.128:    Singapore COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.129:    Singapore COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.130:    Australia COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.131:    Australia Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.132:    Australia COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.133:    Australia COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.134:    Australia COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.135:    Australia COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.136:    Australia COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.137:    Bangladesh COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.138:    Bangladesh Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.139:    Bangladesh COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.140:    Bangladesh COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.141:    Bangladesh COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.142:    Bangladesh COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.143:    Bangladesh COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.144:    Pakistan COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.145:    Pakistan Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.146:    Pakistan COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.147:    Pakistan COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.148:    Pakistan COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.149:    Pakistan COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.150:    Pakistan COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.151:    Indonesia COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.152:    Indonesia Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.153:    Indonesia COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.154:    Indonesia COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume, 1Q2020-4Q2021
Figure 12.155:    Indonesia COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.156:    Indonesia COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.157:    Indonesia COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.158:    RoAPAC COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.159:    Rest-of-APAC COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.160:    Rest-of-APAC COVID-19 Diagnostic Testing Market (for Molecular Assays, Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.161:    Rest-of-APAC COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), Q12020-4Q2021
Figure 12.162:    Rest-of-APAC COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.163:    Rest-of-APAC COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.164:    Latin America COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.165:    Latin America: Market Dynamics
Figure 12.166:    Latin America COVID-19 Diagnostic Testing Market (by Country), Value ($Million), 1Q2020-4Q2021
Figure 12.167:    Brazil COVID-19 Diagnostic Testing Market, Value ($Million), 3Q2020-4Q2021
Figure 12.168:    Brazil Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.169:    Brazil COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.170:    Brazil COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.171:    Brazil COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.172:    Brazil COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.173:    Brazil COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.174:    Mexico COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.175:    Mexico Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.176:    Mexico COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.177:    Mexico COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.178:    Mexico COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.179:    Mexico COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.180:    Mexico COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.181:    Peru COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.182:    Peru Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.183:    Peru COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.184:    Peru COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.185:    Peru COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.186:    Peru COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.187:    Peru COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.188:    Argentina COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.189:    Argentina Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.190:    Argentina COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.191:    Argentina COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.192:    Argentina COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.193:    Argentina COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.194:    Argentina COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.195:    Chile COVID-19 Diagnostic Testing Market, $Million, Q12020-Q42021
Figure 12.196:    Chile Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.197:    Chile COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.198:    Chile COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.199:    Chile COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.200:    Chile COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.201:    Chile COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.202:    RoLA COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.203:    Rest-of-Latin America COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.204:    Rest-of-Latin America COVID-19 Diagnostic Testing Market (for Molecular Assays, Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.205:    Rest-of-Latin America COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), Q12020-4Q2021
Figure 12.206:    Rest-of-Latin America COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.207:    Rest-of-Latin America COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.208:    Middle East COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.209:    Middle East: Market Dynamics
Figure 12.210:    Middle East COVID-19 Diagnostic Testing Market (by Country), Value ($Million), 1Q2020-4Q2021
Figure 12.211:    KSA COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.212:    KSA Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.213:    KSA COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.214:    KSA COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.215:    KSA COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.216:    KSA COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.217:    KSA COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.218:    Iran COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.219:    Iran Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.220:    Iran COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.221:    Iran COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.222:    Iran COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.223:    Iran COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.224:    Iran COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.225:    U.A.E. COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.226:    U.A.E. Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.227:    U.A.E. COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.228:    U.A.E. COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.229:    U.A.E. COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.230:    U.A.E. COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.231:    U.A.E. COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.232:    Rest-of-Middle East COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.233:    Rest-of-Middle East COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.234:    Rest-of-Middle East COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.235:    Rest-of-Middle East COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.236:    Rest-of-Middle East COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.237:    Rest-of-Middle East COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.238:    Africa COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.239:    Africa: Market Dynamics
Figure 12.240:    Africa COVID-19 Diagnostic Testing Market (by Country), Value ($Million), 1Q2020-4Q2021
Figure 12.241:    South Africa COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.242:    South Africa Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.243:    South Africa COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.244:    South Africa COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.245:    South Africa COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.246:    South Africa COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.247:    South Africa COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.248:    Zimbabwe COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.249:    Zimbabwe Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.250:    Zimbabwe COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.251:    Zimbabwe COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.252:    Zimbabwe COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.253:    Zimbabwe COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.254:    Zimbabwe COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.255:    Algeria COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.256:    Algeria Month-Wise COVID-19 Cases, as of August 15, 2020
Figure 12.257:    Algeria COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.258:    Algeria COVID-19 Diagnostic Testing Market (by Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.259:    Algeria COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.260:    Algeria COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.261:    Algeria COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.262:    Rest-of-Africa COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.263:    Rest-of-Africa COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.264:    Rest-of-Africa COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.265:    Rest-of-Africa COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.266:    Rest-of-Africa COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.267:    Rest-of-Africa COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 12.268:    Oceania/RoW COVID-19 Diagnostic Testing Market, Value ($Million), 1Q2020-4Q2021
Figure 12.269:    Oceania/RoW COVID-19 Diagnostic Testing Market (by Technology), Value ($Million), 1Q2020-4Q2021
Figure 12.270:    Oceania/RoW COVID-19 Diagnostic Testing Market (for Molecular Assays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.271:    Oceania/RoW COVID-19 Diagnostic Testing Market (for Molecular Assays), Value ($Million), 1Q2020-4Q2021
Figure 12.272:    Oceania/RoW COVID-19 Diagnostic Testing Market (for Immunoassays), Volume (Thousand Units), 1Q2020-4Q2021
Figure 12.273:    Oceania/RoW COVID-19 Diagnostic Testing Market (for Immunoassays), Value ($Million), 1Q2020-4Q2021
Figure 13.1:    Total Number of Companies Profiled
Figure 13.2:    Competitive Benchmarking of Abbott Laboratories
Figure 13.3:    Competitive Benchmarking of BGI Group
Figure 13.4:    Competitive Benchmarking of Becton, Dickinson and Company
Figure 13.5:    Competitive Benchmarking of BioMerieux SA
Figure 13.6:    Competitive Benchmarking of Bio-Rad Laboratories, Inc.
Figure 13.7:    Competitive Benchmarking of CENTOGENE Holding AG
Figure 13.8:    Competitive Benchmarking of Cellex Inc.
Figure 13.9:    Competitive Benchmarking of CTK Biotech
Figure 13.10:    Competitive Benchmarking of Danaher Corporation
Figure 13.11:    Competitive Benchmarking of DiaSorin S.p.A
Figure 13.12:    Competitive Benchmarking of F. Hoffmann-La Roche Ltd
Figure 13.13:    Competitive Benchmarking of Hologic, Inc.
Figure 13.14:    Competitive Benchmarking of GenMark Diagnostics
Figure 13.15:    Competitive Benchmarking of PerkinElmer Inc.
Figure 13.16:    Competitive Benchmarking of QIAGEN N.V.
Figure 13.17:    Competitive Benchmarking of Quidel Corporation
Figure 13.18:    Competitive Benchmarking of Luminex Corporation
Figure 13.19:    Competitive Benchmarking of Siemens Healthineers AG
Figure 13.20:    Competitive Benchmarking of Thermo Fisher Scientific Inc.

FAQ's

What is the current market size for COVID-19 diagnostic testing?

Answer – As per our research analysis, the global COVID-19 diagnostic testing market has generated $10.04 billion by the third quarter of 2020.

Which factors influence the growth opportunities of this emerging tech market?

Answer – The rising cases of COVID-19 worldwide, significant external funding, technological innovation, and favorable regulatory scenario have fueled the growth and demand for COVID-19 diagnostic testing.

Which is the leading market player in the sector?

Answer – Abbott Laboratories has been dominating the COVID-19 diagnostic testing market worldwide due to its diverse product and pipeline portfolio and intense market penetration.

Which product within the COVID-19 diagnostic testing market is observing the highest adoption?

Answer – The kits and assays segment is witnessing huge developments in the field of COVID-19 diagnostic testing solutions due to the increased penetration from emerging and legacy diagnostic companies worldwide.

Which region holds the largest market share in the COVID-19 diagnostic testing market?

Answer – The Asia-Pacific region occupies a major market share in the global market for COVID-19 diagnostic testing due to the rising number of COVID-19 cases, growing emphasis on the development of novel diagnostic technologies, and elevating healthcare awareness amongst the population.

You may also like

Published Year: 2020

Global In Vitro Diagnostic Market: Focus on Product, Test Type, Application, End User, Region and Co

The global market for IVD is predicted to grow at a CAGR of 5.06% over the forecast period of...

 
Published Year: 2020

Global Infectious Disease Rapid Diagnostic Testing Market: Focus on Product, Disease, Technology, Ap

The global market for infectious disease rapid diagnostics is predicted to grow at a CAGR of...

 

Global COVID-19 Diagnostic Testing Market

Focus on Product Type, Sample Type, Technology, End User, Country Data (30 Countries), and Competitive Landscape - Analysis and Forecast, 3Q-2020-4Q-2021